Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP24A1 | Q07973 | 8/20 | 0.56 |
| ▸ | CYP27B1 | O15528 | 2/20 | 0.56 |
| ▸ | CYP17A1 | P05093 | 3/20 | 0.53 |
| ▸ | NT5E | P21589 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | CA12 | O43570 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA9 | Q16790 | 1/20 | 0.47 |
| ▸ | NAMPT | P43490 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | CYP26A1 | O43174 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9784390 | 0.91 | CYP17A1 (0.55) | CYP24A1CYP27B1CYP17A1NAMPT | |
| SCHEMBL9788661 | 0.90 | CYP17A1 (0.63) | CYP24A1CYP27B1CYP17A1 | |
| SCHEMBL9784334 | 0.85 | NPC1 (0.58) | CYP17A1MAPK1NAMPT | |
| SCHEMBL9728444 | 0.83 | CYP17A1 (0.61) | CYP17A1KMT2A | |
| SCHEMBL9784341 | 0.80 | CYP17A1 (0.55) | CYP24A1CYP27B1CYP17A1KMT2AMAPK1 | |
| SCHEMBL9784342 | 0.80 | CYP17A1 (0.64) | CYP24A1CYP17A1 | |
| SCHEMBL9784409 | 0.80 | CYP17A1 (0.67) | CYP24A1CYP27B1CYP17A1 | |
| SCHEMBL2351781 | 0.79 | CYP17A1 (0.60) | CYP24A1CYP27B1CYP17A1CYP26A1 | |
| SCHEMBL9784371 | 0.79 | CYP17A1 (0.62) | CYP24A1CYP17A1 | |
| SCHEMBL9784330 | 0.79 | CYP17A1 (0.62) | CYP24A1CYP17A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5045558-A | Aromatase inhibitors, prevention of estrogen biosynthesis, treatment of breast cancer | SCHERING AKTIENGESELLSCHAFT (DE) | 1991-09-03 | — | — | US | disclosed |